This case report study describes a refractory DLBCL patient who developed CNS relapse and was successfully treated with anti-CD19 CAR-T cell therapy plus BTK inhibitor and PD-1 antibody. The gene discussed is PDCD1; the disease is diffuse large B-cell lymphoma.